Your AI-Trained Oncology Knowledge Connection!

Opinion

Video

Emerging Targeted Treatment Options for Patients With Advanced Endometrial Cancer

Author(s):

Ramez N. Eskander, MD,Krishnansu Tewari, MD

Key opinion leaders discuss targeted treatment regimens for advanced or recurrent endometrial cancer that are currently under development.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Elizabeth Lee, MD, a gynecologic oncologist and the gynecologic oncology program's liaison to the Center for Cancer Therapeutics Innovation at Dana-Farber Cancer Institute
Taliya Lantsman, MD, a hematology/oncology fellow at Beth Israel Deaconess Medical Center
Shannon N. Westin, MD, MPH, FACOG, director, Early Drug Development, clinical medical director, professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, codirector, Ovarian Cancer Moonshot Program, The University of Texas MD Anderson Cancer Center
Jordyn Silverstein, MD
Rachel N. Grisham, MD
Toon Van Gorp, MD, PhD
Matthew Wagar, MD of the University of Wisconsin School of Medicine and Public Health
Dr Salani on Novel Trial Designs and Therapies in Gynecologic Malignancies
Matthew Wagar, MD of the University of Wisconsin School of Medicine and Public Health
Emily M. Hinchcliff, MD, MPH, assistant professor, Feinberg School of Medicine, Northwestern Medicine
Related Content
The top 5 OncLive videos of the week cover insights in gynecologic cancer, multiple myeloma, urothelial cancer, MPNs, and prostate cancer.
March 23rd 2025

Five Under 5: Top Oncology Videos for the Week of 3/16

Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD
January 11th 2024

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

Gynecologic Oncology | Image Credit: © Crystal light - stock.adobe.com
March 21st 2025

Emerging ADCs, Biomarker-Driven Treatments, and Diagnostic Advancements Take Center Stage at the SGO Annual Meeting

R. Wendel Naumann, MD
October 26th 2023

Naumann Discusses Notable Research Efforts in Endometrial Cancer

Selinexor in Endometrial Cancer
March 17th 2025

Maintenance Selinexor Extends PFS in TP53 Wild-Type Endometrial Cancer

Image Credit: © Katsyarina – stock.adobe.com
March 17th 2025

Dostarlimab/Chemo Improves Long-Term DOR in Advanced Endometrial Cancer